文献速递关节外科

2018年John Charnley奖:美国髋关节置换捆绑支付分析——医生发起的病例优于医院发起的病例

2018 John Charnley Award: Analysis of US Hip Replacement Bundled Payments: Physician-initiated Episodes Outperform Hospital-initiated Episodes.
PubMed 文献 · Clin Orthop Relat Res · 2019-01-01

该回顾性分析基于2013年1月至2016年3月美国(除马里兰外)所有Medicare初次择期全髋关节置换术(无重大合并症)的CMS Limited Data Set数据,比较医院主导的BPCI、医生执业团体(PGP)主导的BPCI及非BPCI病例的90天支付、再入院和死亡率。结果显示BPCI与支付降低相关(全体下降4.44%,PGP下降4.81%,医院下降4.04%),再入院和死亡率无变化,PGP主导的支付降幅大于医院主导。

要点

  • BPCI与择期全髋关节置换术90天支付降低相关,全体下降4.44%(95%CI -4.58%至-4.30%,p<0.001),再入院和死亡率无变化。
  • PGP主导的BPCI支付下降4.81%(95%CI -5.01%至-4.61%,p<0.001),大于医院主导的4.04%(95%CI -4.24%至3.84%,p<0.01)。
  • BPCI前后患者年龄和平均Elixhauser合并症指数无变化,支付降低并非因选择年轻或合并症少的患者。

核心结论

  • 在控制传统按服务付费成本下降趋势后,BPCI与支付降低相关且不良事件无变化,并非因选择年轻或合并症少的患者。
  • 医生执业团体主导的BPCI支付降幅大于医院主导的BPCI,两者再入院或死亡率较基线均无差异。
  • 作者认为,在未来医疗改革中,医生可能比医院更适合管理支付降低。

研究设计与样本

  • 病例分为医院主导的BPCI(n=42,922)、PGP主导的BPCI(n=44,662)和非BPCI的THA(n=284,002)。
  • 计算术后90天所有Medicare Part A支付并按通货膨胀和地区差异调整,采用logistic回归比较各组支付、再入院和死亡率,控制年龄、性别、种族、地理位置、背景趋势和Elixhauser合并症。

主要发现

  • 在控制人口学、背景趋势、地区差异和总Elixhauser合并症后,BPCI与全体参与者支付下降4.44%相关(95%CI -4.58%至-4.30%,p<0.001),从基线18,802美元下降1,244美元;90天死亡率和再入院的OR无变化。
  • PGP组加入BPCI后支付下降4.81%(95%CI -5.01%至-4.61%,p<0.001),从基线17,841美元下降1,335美元。
  • 医院组加入BPCI后支付下降4.04%(95%CI -4.24%至3.84%,p<0.01),从基线19,799美元下降1,138美元。
  • PGP主导病例的支付降幅大于医院主导病例;PGP和医院主导的BPCI项目在BPCI后90天死亡率和再入院OR均无变化。
  • PGP主导、医院主导或整体BPCI病例在BPCI后患者年龄和平均Elixhauser合并症指数均无变化。

关键数值与推荐

  • BPCI全体参与者支付下降4.44%(95%CI -4.58%至-4.30%,p<0.001),从基线18,802美元下降1,244美元。
  • PGP组支付下降4.81%(95%CI -5.01%至-4.61%,p<0.001),从基线17,841美元下降1,335美元。
  • 医院组支付下降4.04%(95%CI -4.24%至3.84%,p<0.01),从基线19,799美元下降1,138美元。
  • BPCI后90天死亡率和再入院的OR无变化;患者年龄和平均Elixhauser合并症指数无变化。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Centers for Medicare & Medicaid Services (CMS) launched the Bundled Payment for Care Improvement (BPCI) initiative in 2013 to create incentives to improve outcomes and reduce costs in various clinical settings, including total hip arthroplasty (THA). This study seeks to quantify BPCI initiative outcomes for THA and to determine the optimal party (for example, hospital versus physician group practice [PGP]) to manage the program. QUESTIONS/PURPOSES: (1) Is BPCI associated with lower 90-day payments, readmissions, or mortality for elective THA? (2) Is there a difference in 90-day payments, readmissions, or mortality between episodes initiated by PGPs and episodes initiated by hospitals for elective THA? (3) Is BPCI associated with reduced total Elixhauser comorbidity index or age for elective THA? METHODS: We performed a retrospective analysis on the CMS Limited Data Set on all Medicare primary elective THAs without a major comorbidity performed in the United States (except Maryland) between January 2013 and March 2016, totaling more than USD 7.1 billion in expenditures. Episodes were grouped into hospital-run BPCI (n = 42,922), PGP-run BPCI (n = 44,662), and THA performed outside of BPCI (n = 284,002). All Medicare Part A payments were calculated over a 90-day period after surgery and adjusted for inflation and regional variation. For each episode, age, sex, race, geographic location, background trend, and Elixhauser comorbidities were determined to control for major confounding variables. Total payments, readmissions, and mortality were compared among the groups with logistic regression. RESULTS: When controlling for demographics, background trend, geographic variation, and total Elixhauser comorbidities in elective Diagnosis-Related Group 470 THA episodes, BPCI was associated with a 4.44% (95% confidence interval [CI], -4.58% to -4.30%; p < 0.001) payment decrease for all participants (USD 1244 decrease from a baseline of USD 18,802); additionally, odds ratios (ORs) for 90-day mortality and readmissions were unchanged. PGP groups showed a 4.81% decrease in payments (95% CI, -5.01% to -4.61%; p < 0.001) after enrolling in BPCI (USD 1335 decrease from a baseline of USD 17,841). Hospital groups showed a 4.04% decrease in payments (95% CI, -4.24% to 3.84%; p < 0.01) after enrolling in BPCI (USD 1138 decrease from a baseline of USD 19,799). The decrease in payments of PGP-run episodes was greater compared with hospital-run episodes. ORs for 90-day mortality and readmission remained unchanged after BPCI for PGP- and hospital-run BPCI programs. Patient age and mean Elixhauser comorbidity index did not change after BPCI for PGP-run, hospital-run, or overall BPCI episodes. CONCLUSIONS: Even when controlling for decreasing costs in traditional fee-for-service care, BPCI is associated with payment reduction with no change in adverse events, and this is not because of the selection of younger patients or those with fewer comorbidities. Furthermore, physician group practices were associated with greater payment reduction than hospital programs with no difference in readmission or mortality from baseline for either. Physicians may be a more logical group than hospitals to manage payment reduction in future healthcare reform. LEVEL OF EVIDENCE: Level II, economic and decision analysis.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Murphy WS, Siddiqi A, Cheng T, et al. 2018 John Charnley Award: Analysis of US Hip Replacement Bundled Payments: Physician-initiated Episodes Outperform Hospital-initiated Episodes. Clin Orthop Relat Res. 2019. PMID: 30664603. doi:10.1097/CORR.0000000000000532

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。